In CRC, ADAR-mediated RNA editing at 3ʹ-UTR of PVR could upregulate its expression by increasing the RNA stability, leading to tumor- and immune-related gene functions and pathways in CRC (Qian et al., 2024). The gene discussed is ADAR; the disease is neoplasm.